Traditional methods to detect Salmonella in poultry and trace outbreaks often fail to give the full picture of the threat in enough time for integrators to act. This lack of oversight limits the effectiveness of intervention strategies designed to mitigate Salmonella transmission.
The global poultry industry spends billions of dollars annually to help ensure flock health, welfare, efficiency and performance. Faced with rising costs, a major US poultry company recently partnered with Ancera to monitor the effectiveness of its program for controlling coccidiosis.
Necrotic enteritis (NE) is a devastating disease characterized by severe gut inflammation and sudden death, which can lead to significant economic losses. A new instrument from Ancera can help identify Clostridium perfringens, the causative agent of NE, early enough to help producers treat or prevent NE.
Conventional diagnostic methods for detecting Salmonella in live poultry production typically rely on analyzing isolated bacterial colonies from enriched samples. Recent evidence, however, suggests these methods can overlook the presence of certain strains and serotypes.
Ancera has released a new suite of comprehensive monitoring tools to provide allied companies of the poultry industry with real-time, third-party evidence demonstrating product efficacy.
As poultry companies continue to increase their oversight of products in response to tightening margins, suppliers are under greater pressure to provide third-party data demonstrating product efficacy.
